Persistent neuromuscular disorders associated with changes in tibialis anterior and gastrocnemius lateralis muscle architecture in LC: study, 2025

Mij

Senior Member (Voting Rights)
Full Title: Persistent neuromuscular disorders associated with changes in tibialis anterior and gastrocnemius lateralis muscle architecture in long-covid: an observational longitudinal study, 2025, Isabella da Silva Almeida et al

Abstract

Long COVID-19 causes complications, affecting quality of life and work capacity. However, its long-term impact on lower limb neuromuscular function remains unclear.

To evaluate neuromuscular electrophysiological disorders (NEDs) and muscle architecture of the tibialis anterior (TA) and triceps surae (TS) in individuals with moderate or severe COVID-19 compared to control group over 12 months. Seventy participants were divided into moderate-COVID (n = 22), severe-COVID (n = 18), and control (n = 30) groups. COVID groups underwent four assessments over one year. NEDs in the TA and gastrocnemius lateralis (GL) were assessed via stimulus electrodiagnostic testing, while TA and TS muscle architecture was evaluated using ultrasound.

Participants with severe-COVID exhibited significantly higher chronaxie (p < 0.001) in the TA at the first assessment, NEDs were observed in 55.55%, 33.33%, and 16.66% of participants across the first three assessments. GL showed 5.55% prevalence of NEDs. Echogenicity increased in TA and GL muscles in the severe-COVID group (p < 0.001). An association was found between TA chronaxie and echogenicity in the COVID groups during the short-term assessment (p < 0.001).

Severe COVID-19 is associated with higher prevalence of NEDs in the TA muscle and persistent echogenicity increases, suggesting polyneuromyopathy in the TA and widespread echogenicity abnormalities in long COVID patients.
LINK

 
Conclusion

Individuals who had severe COVID-19 show a higher prevalence of NEDs in the TA muscle, associated with increased echogenicity that persists in all analyzed muscles, especially in the TA, over one year. Clinicians should consider the time elapsed since the COVID-19 diagnosis, the severity of the cases, and the assessed muscle when recommending more targeted treatment strategies for individuals with long COVID-19.
 
In our study, participants in the severe COVID-19 group exhibited higher BMI, a greater number of comorbidities, advanced age, and lower levels of physical activity. These well-established risk factors not only increase the likelihood of developing more severe forms of COVID-19 and subsequent hospitalization but may also explain our findings
 
Back
Top Bottom